148 related articles for article (PubMed ID: 23877431)
1. Sildenafil weaning after discharge in infants with congenital diaphragmatic hernia.
Behrsin J; Cheung M; Patel N
Pediatr Cardiol; 2013; 34(8):1844-7. PubMed ID: 23877431
[TBL] [Abstract][Full Text] [Related]
2. Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia.
Luong C; Rey-Perra J; Vadivel A; Gilmour G; Sauve Y; Koonen D; Walker D; Todd KG; Gressens P; Kassiri Z; Nadeem K; Morgan B; Eaton F; Dyck JR; Archer SL; Thébaud B
Circulation; 2011 May; 123(19):2120-31. PubMed ID: 21537000
[TBL] [Abstract][Full Text] [Related]
3. Intravenous sildenafil in the management of pulmonary hypertension associated with congenital diaphragmatic hernia.
Bialkowski A; Moenkemeyer F; Patel N
Eur J Pediatr Surg; 2015 Apr; 25(2):171-6. PubMed ID: 24163194
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil use in congenital diaphragmatic hernia.
Hunter L; Richens T; Davis C; Walker G; Simpson JH
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F467. PubMed ID: 19846401
[No Abstract] [Full Text] [Related]
5. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.
Mourani PM; Sontag MK; Ivy DD; Abman SH
J Pediatr; 2009 Mar; 154(3):379-84, 384.e1-2. PubMed ID: 18950791
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia.
Keller RL; Hamrick SE; Kitterman JA; Fineman JR; Hawgood S
Pediatr Crit Care Med; 2004 Mar; 5(2):184-7. PubMed ID: 14987351
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
Noori S; Friedlich P; Wong P; Garingo A; Seri I
Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
[TBL] [Abstract][Full Text] [Related]
9. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.
El Midany AA; Mostafa EA; Azab S; Hassan GA
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):963-8. PubMed ID: 23985411
[TBL] [Abstract][Full Text] [Related]
10. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
12. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
13. Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants.
Stultz JS; Puthoff T; Backes C; Nahata MC
Am J Health Syst Pharm; 2013 Mar; 70(5):407-13. PubMed ID: 23413163
[TBL] [Abstract][Full Text] [Related]
14. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the therapeutic and side effects of tadalafil and sildenafil in children and adolescents with pulmonary arterial hypertension.
Sabri MR; Beheshtian E
Pediatr Cardiol; 2014 Apr; 35(4):699-704. PubMed ID: 24253611
[TBL] [Abstract][Full Text] [Related]
16. Safety of sildenafil in infants*.
Samiee-Zafarghandy S; Smith PB; van den Anker JN
Pediatr Crit Care Med; 2014 May; 15(4):362-8. PubMed ID: 24583505
[TBL] [Abstract][Full Text] [Related]
17. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
Lee JE; Hillier SC; Knoderer CA
J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
[TBL] [Abstract][Full Text] [Related]
18. Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia.
Kipfmueller F; Schroeder L; Berg C; Heindel K; Bartmann P; Mueller A
Pediatr Pulmonol; 2018 Apr; 53(4):452-460. PubMed ID: 29316358
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic modeling of intravenous sildenafil in newborns with congenital diaphragmatic hernia.
Cochius-den Otter SCM; Kipfmueller F; de Winter BCM; Allegaert K; Tibboel D; Mueller A; Koch BCP
Eur J Clin Pharmacol; 2020 Feb; 76(2):219-227. PubMed ID: 31740991
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil for the treatment of pulmonary hypertension in pediatric patients.
Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES
Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
